ホーム>>Signaling Pathways>> Microbiology & Virology>> Antimalaria>>Artemether (SM-224)

Artemether (SM-224) (Synonyms: (+)-Artemether, SM-224)

カタログ番号GC12784

寄生虫防止剤

Products are for research use only. Not for human use. We do not sell to patients.

Artemether (SM-224) 化学構造

Cas No.: 71963-77-4

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO) Please Inquire Please Inquire
10mg
$0.00
在庫あり
25mg
$0.00
在庫あり
50mg
$0.00
在庫あり
100mg
$45.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Artemether is a semi-synthetic derivative of artemisinin (qinghaosu), a naturally occurring peroxide lactone derived from a traditional Chinese herbal remedy Artemisia annua L., to enhance the solubility and antimalarial activity of its parental compound. Artemether exhibits potent antimalarial and antischistosomal activities against malarial parasites and Schistosoma japonicum infections. Although it has not been well elucidated, an endoperoxide bridge within the chemical structure of Artemether might be the key characteristic considered to be responsible for its antimalarial and antischistosomal activities, which can be metabolized by malarial or schistosomal parasites, under in vivo conditions, generating detrimental oxygen radicals to attack parasite macromolecules.

Reference

 [1].Xiao Shuhua and Brian A. Catto.  In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 1989, 1557-1562

レビュー

Review for Artemether (SM-224)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Artemether (SM-224)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.